Figure 1.
Incidence of somatoform symptoms in patients with gastroesophageal reflux disease. Group A: patients with indication for surgery, willing to undergo surgery. The percentage of SSI ≥ 17 was 22%; Group B: Patients with GERD and indication for surgery, who has refused antireflux surgery and have continued protonpump inhibitors therapy. The percentage of SSI ≥ 17 was 20%. GERD: Gastroesophageal reflux disease; SSI: Somatoform Symptom Index.